Compare · ILMN vs TRUP
ILMN vs TRUP
Side-by-side comparison of Illumina Inc. (ILMN) and Trupanion Inc. (TRUP): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ILMN and TRUP operate in Medical Specialities (Health Care), so they compete in similar markets.
- ILMN is the larger of the two at $23.91B, about 24.9x TRUP ($961.8M).
- Over the past year, ILMN is up 86.1% and TRUP is down 56.8% - ILMN leads by 142.9 points.
- ILMN has been more active in the news (22 items in the past 4 weeks vs 14 for TRUP).
- ILMN has more recent analyst coverage (25 ratings vs 12 for TRUP).
- Company
- Illumina Inc.
- Trupanion Inc.
- Price
- $158.13-2.55%
- $22.06+0.23%
- Market cap
- $23.91B
- $961.8M
- 1M return
- +14.02%
- -13.66%
- 1Y return
- +86.08%
- -56.78%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2000
- News (4w)
- 22
- 14
- Recent ratings
- 25
- 12
Illumina Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Trupanion Inc.
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Latest ILMN
- Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution
- SVP, Chief People Officer Leckman Patricia sold $127,068 worth of shares (784 units at $162.08), decreasing direct ownership by 3% to 22,042 units (SEC Form 4)
- Director Meister Keith A. sold $107,042,631 worth of shares (669,596 units at $159.86) (SEC Form 4)
- Chief Legal Officer Davies Scott M sold $98,400 worth of shares (615 units at $160.00), decreasing direct ownership by 3% to 21,568 units (SEC Form 4)
- VP, Chief Accounting Officer Ericksen Scott D sold $305,150 worth of shares (2,000 units at $152.57), decreasing direct ownership by 12% to 14,446 units (SEC Form 4)
- Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights
- Amendment: SEC Form 4 filed by Director Meister Keith A.
- Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research
- Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research
- Illumina Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
Latest TRUP
- Amendment: SEC Form 4 filed by EVP, Trupanion International Wheeler Simon
- Amendment: SEC Form 4 filed by EVP, Trupanion International Wheeler Simon
- Chief Operating Officer Gallagher John R sold $78,153 worth of shares (3,603 units at $21.69) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 33,065 units (SEC Form 4)
- EVP, Trupanion International Wheeler Simon converted options into 2,169 shares and covered exercise/tax liability with 1,017 shares, increasing direct ownership by 5% to 24,239 units (SEC Form 4) (withholding obligation)
- Director Rawlings Darryl converted options into 312 shares, increasing direct ownership by 1% to 24,838 units (SEC Form 4) to cover withholding tax
- CEO Tooth Margaret covered exercise/tax liability with 6,999 shares, sold $10,733 worth of shares (491 units at $21.86) and converted options into 19,042 shares, increasing direct ownership by 7% to 176,379 units (SEC Form 4) to cover withholding tax
- Chief Administration Officer Mcgibney Brenna converted options into 6,431 shares and covered exercise/tax liability with 3,439 shares, increasing direct ownership by 35% to 11,445 units (SEC Form 4) (tax withholding)
- Chief Operating Officer Gallagher John R converted options into 6,793 shares and covered exercise/tax liability with 1,651 shares, increasing direct ownership by 16% to 36,668 units (SEC Form 4) (withholding obligation)
- Director Rubin Howard E converted options into 318 shares, increasing direct ownership by 0.14% to 232,868 units (SEC Form 4)
- Director Powell Bradley S converted options into 639 shares, increasing direct ownership by 50% to 1,906 units (SEC Form 4)